ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy

Tianxiao Wang(Henan University), Qunyi Li(Fudan University)
Journal of Translational Medicine
September 7, 2023
Cited by 16


Related Papers